A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Transplante de páncreas; Trasplante del páncreas
Los riesgos de cualquier cirugía son:
Los riesgos del trasplante de páncreas abarcan:
El sistema inmunitario del cuerpo considera al órgano trasplantado como un extraño y lo combate. Para prevenir el rechazo, los pacientes con trasplante de órgano deben tomar medicamentos (tales como ciclosporina y corticosteroides) que debilitan la respuesta inmunitaria del cuerpo. Esto hace que la persona tenga menor capacidad de combatir infecciones y puede causar otros problemas de salud.
Lipshutz GS, Wilkinson AH. Pancreas-kidney and pancreas transplantation for the treatment of diabetes mellitus. Endocrinol Metab Clin North Am. 2007;36(4).
White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009; 373(9677):1808-1817.
Markmann FJ, Yeh H, Naji A, et al. Transplantation of abdominal organs. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2008: chap 28.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885